• 1
    Feitelson M. Hepatitis B virus infection and primary hepatocellular carcinoma. Clin Microbiol Rev 1992; 5:275301. MEDLINE
  • 2
    Pol S, Driss F, Carnot F, Michel ML, Berthelot P, Brechot C. Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication. C R Acad Sci III 1993; 316:688691. MEDLINE
  • 3
    Pol S, Driss F, Michel ML, Nalpas B, Berthelot P, Brechot C. Specific vaccine therapy in chronic hepatitis B infection. Lancet 1994; 344:342. MEDLINE
  • 4
    Akbar SM, Kajino K, Tanimoto K, Kurose K, Masumoto T, Michitaka K, Horiike N, et al. Placebo-controlled trial of vaccination with hepatitis B virus surface antigen in hepatitis B virus transgenic mice. J Hepatol 1997; 26:131137. MEDLINE
  • 5
    Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel M. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci U S A 1996; 93:1249612501. MEDLINE
  • 6
    Ma ZM, Kong YY, Wang Y, Wen YM. Recombinant vaccinia virus expressing Pre-S/S protein of duck hepatitis B virus and its preliminary use for treatment of persistent infection. Acta Virol 1996; 40:311314. MEDLINE
  • 7
    Rollier C, Sunyach C, Barraud L, Madani N, Jamard C, Trepo C, Cova L. Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology 1999; 116:658665. MEDLINE
  • 8
    Prince AM, Whalen R, Taylor PE, Brotman B. Protective efficacy of DNA-based immunization against HBV in newborn chimpanzees. Vaccines 97. Cold Spring Harbor Laboratory, NY, 1997;141144.
  • 9
    Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986; 47:451460. MEDLINE
  • 10
    Tartaglia J, Perkus ME, Taylor J, Norton EK, Audonnet JC, Cox WI, Davis SW, et al. NYVAC: a highly attenuated strain of vaccinia virus. Virology 1992; 188:217232. MEDLINE
  • 11
    Perkus ME, Kauffman EB, Taylor J, Mercer S, Smith D, Vander Hoven J, Paoletti E, et al. Methodology of using vaccinia virus to express foreign genes in tissue culture. Tiss Cult Meth 1993; 15:7281.
  • 12
    Perkus ME, Limbach K, Paoletti E. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J Virol 1989; 63:38293836. MEDLINE
  • 13
    Wang CN, Wu KY, Wang HT. Detection of PCR products: quantitation and analysis. In: DieffenbachCW, DvekslerGS, eds. PCR Primer: A Laboratory Manual. Cold Spring Harbor Laboratory Press, NY, 1995;193202.
  • 14
    Gunther S, Meisel H, Reip A, Miska S, Kruger DH, Will H. Frequent and rapid emergence of mutated pre-C sequences in HBV from e-antigen positive carriers who seroconvert to anti-HBe during interferon treatment. Virology 1992; 187:271279. MEDLINE
  • 15
    Kock J, Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996; 23:405413. MEDLINE
  • 16
    Honorati MC, Dolzani P, Mariani E, Piacentini A, Lisignoli G, Ferrari C, Facchini A. Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. Gastroenterology 1997; 112:20172027. MEDLINE
  • 17
    Livingston BD, Alexander J, Crimi C, Oseroff C, Celis E, Daly K, Guidotti LG, et al. Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. J Immunol 1999; 162:30883095. MEDLINE
  • 18
    Chisari FV. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol 1996; 206:149173. MEDLINE
  • 19
    Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari F. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A 1994; 91:37643768. MEDLINE
  • 20
    Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Immunity 1996; 4:2536. MEDLINE
  • 21
    Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825829. MEDLINE
  • 22
    Jung MC, Hartmann B, Gerlach JT, Diepolder H, Gruber R, Schraut W, Gruner N, et al. Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology 1999; 261:165172. MEDLINE
  • 23
    Cavanaugh VJ, Guidotti LG, Chisari FV. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol 1997; 71:32363243. MEDLINE
  • 24
    Tay CH, Szomolanyi-Tsuda E, Welsh RM. Control of infections by NK cells. Curr Top Microbiol Immunol 1998; 230:193220. MEDLINE